期刊文献+

青海撒拉族和汉族健康人群CYP2C19m1多态性分析 被引量:5

STUDY ON CYTOCHROME CYP2C19 M1 GENETIC POLYMORPHISM IN QINGHAI SALA AND HAN NATIONALITIES
下载PDF
导出
摘要 目的分析青海撒拉族和汉族健康人群CYP2C19 m1的多态性。方法采用PCR-RFLP技术对99例健康撒拉族和78例健康汉族人群CYP2C19 m1基因进行扩增及图谱分析。结果撒拉族与汉族CYP2C19 m1各种基因型出现频率分别为,wt/wt:0.455,0.474;wt/m1:0.485,0.439;m1/m1:0.061,0.088。撒拉族与汉族各种CYP2C19等位基因出现频率分别为,wt:0.697,0.692;m1:0.303,0.308。结论青海撒拉族人群的CYP2C19 m1基因频率分布状况与青海汉族人群接近。 Objective To study the polymorphism of CYP2C19 in Qinghai Sala and Han nationalities.Methods CYP2C19 m1 mutant alleles was detected using polymerase chain reaction-restriction fragment length polymorphism method(PCR-RFLP).Results CYP2C19 genotype frequencies in Qinghai Sala and Han nationalities were wt/wt:0.455,0.474;wt/m1:0.485,0.439 and m1/m1:0.061,0.088.CYP2C19 allele frequencies were wt:0.697,0.692 and ml:0.303,0.308.Conclusion The distribution of P-450 2C19 genes in the Sala in Qinghai province is close to those in the Han population.
出处 《青海医学院学报》 CAS 2011年第1期9-12,共4页 Journal of Qinghai Medical College
基金 青海大学医学院中青年科技基金项目 项目编号:qy-2008-02
关键词 CYP2C19 基因多态性 撒拉族 汉族 PCR-RFLP CYP2C19 genotype polymorphism Sala nationality Han nationality PCR-RFLP
  • 相关文献

参考文献7

  • 1De Morais SM F,Wilkinson GR,Blaisdell,et al.The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans[J].J Biolog Chem,1994,269:1549.
  • 2Wichittra.T,Werawath.M,Kanokporn,et al.CYP2C19 genetic polymophism in Thai,Burmese and Karen populations[J].Drug Metab.Pharmacokinet,2006,21(4)286-290.
  • 3阿力木.卡德尔,阿木提.托呼提,牛春燕,罗金燕.维吾尔族和汉族人群CYP2C19基因多态性分析[J].新疆医科大学学报,2007,30(2):130-132. 被引量:9
  • 4付琼瑶,李佩琼,王九辉,蔡望伟.海南黎族人群细胞色素P4502C19基因多态性的研究[J].中国热带医学,2005,5(9):1807-1808. 被引量:9
  • 5Hoskins JM,Shenfield GM,Gross AS.Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population[J].Br J Clin Pharmacol,1998,46(5):499.
  • 6Kubota T,Chiba K,Ishizaki T.Genotypingof S-mephenytoin 4′-hydroxylation in an extended Japanese population[J].Clin Pharmacol Ther,1996,60(6):661.
  • 7闫春兰,詹金彪,陈枢青.浙江省汉族与畲族CYP2C19基因多态性研究[J].中国药学杂志,2004,39(11):866-868. 被引量:12

二级参考文献20

  • 1牛春燕,关丽,罗金燕.维吾尔族健康人群CYP2C19基因多态性分析[J].新疆医科大学学报,2005,28(3):247-249. 被引量:8
  • 2He N, Yan FX, Huang SL. CYP2C19 genotype and S-mephenytoin4 '-hydroxylation phenotype in a Chinese Dai population[J]. Eur J Clin Pharmacol , 2002,58:15.
  • 3Yan S, Zhou HH. Individual and ethnic differences in CYP2C19 activity in Chinese population [J]. Acta Pharmacol Sin, 2000,21 (3): 193.
  • 4Zhou SX, Goldstein JA, Xie HG. Differences in the incidence of the CYP2C19 polymorphism affecting the S-Mephenytoin phenotype in Chinese han and bai population and identification of a new rare CYP2C19 Mutant Allele [J]. J Pharmacol Exp Ther , 1997, 28 (1)
  • 5Tsuneoka Y,Fukushima K,Matsuo Y,Ichikawa Y,Watanabe Y.Genotype analysis of the CYP2C19 gene in the Japanese population[J].Life Sci,1996,59(20):1711~1715.
  • 6Wilkinson GR,Guengerich FP,Branch RA.Genetic polymorphism of S-mephenytoin 4'-hydroxylation[J].Pharmacol Ther 1989,43:53~78.
  • 7De Morais SMF,Wilkinson GR,Blaisdell J,et al.The majoR genetic defect responsible for the polymorphism of S-mephenytoin in humans[J].J Bio Chem,1994,269,15419~15422.
  • 8De Morais SMF,Wilkinson GR,Blaisdell J,et al.Identification a new genetic defect responsible for the polymorphism of S-mephenytoin in Japanese[J].Mol Pharmacol,1994,46,594~598.
  • 9De Morais SM,Goldstein JA,Xie HG,et al.Genetic analysis of the s-mephenytoin polymorphism in a Chinese population[J].Clin Pharmacol Ther,1995,58:404~411.
  • 10Lahiri DK,Schuabel B.DNA isolation by a rapid method from human blood samples:effects of MgCl2,EDTA,storage time,and temperature on DNA yield and quality[J].Bio chem Genet,1993,32∶321~328.

共引文献22

同被引文献39

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部